Back to mobile site

Amgen (AMGN) Receives CRL from FDA on Parsabiv NDA

August 24, 2016 6:06 PM EDT Send to a Friend
Amgen (Nasdaq: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login